rs201817938
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001625.4(AK2):c.661G>A(p.Ala221Thr) variant causes a missense change. The variant allele was found at a frequency of 0.0000787 in 1,613,684 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_001625.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
AK2 | NM_001625.4 | c.661G>A | p.Ala221Thr | missense_variant | Exon 6 of 6 | ENST00000672715.1 | NP_001616.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000723 AC: 11AN: 152124Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000155 AC: 39AN: 251462Hom.: 1 AF XY: 0.000140 AC XY: 19AN XY: 135906
GnomAD4 exome AF: 0.0000794 AC: 116AN: 1461560Hom.: 1 Cov.: 33 AF XY: 0.0000756 AC XY: 55AN XY: 727110
GnomAD4 genome AF: 0.0000723 AC: 11AN: 152124Hom.: 0 Cov.: 32 AF XY: 0.0000807 AC XY: 6AN XY: 74332
ClinVar
Submissions by phenotype
Reticular dysgenesis Uncertain:1
This variant is present in population databases (rs201817938, ExAC 0.2%). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0"). This variant has not been reported in the literature in individuals with AK2-related conditions. This sequence change replaces alanine with threonine at codon 221 of the AK2 protein (p.Ala221Thr). The alanine residue is highly conserved and there is a small physicochemical difference between alanine and threonine. -
Inborn genetic diseases Uncertain:1
The c.661G>A (p.A221T) alteration is located in exon 6 (coding exon 6) of the AK2 gene. This alteration results from a G to A substitution at nucleotide position 661, causing the alanine (A) at amino acid position 221 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at